Literature DB >> 23589475

Prevalence and clinical relevance of extracardiac findings at cardiac MRI.

Jan Martin Sohns1, Alexander Schwarz, Jan Menke, Wieland Staab, Judith Eva Spiro, Joachim Lotz, Christina Unterberg-Buchwald.   

Abstract

PURPOSE: To assess the incidence of extracardiac findings in patients undergoing clinical cardiac magnetic resonance imaging (CMRI) of the heart, and to determine the influence of those findings on patient management.
MATERIALS AND METHODS: During 40 months, 854 CMRI were performed at 1.5 T. Extracardiac findings were classified as significant (group A), if recommended for additional diagnostics or therapeutic interventions, and as nonsignificant (group B).
RESULTS: The most frequent indication for CMRI was evaluation of cardiac stress ischemia. In all, 631 CMRI (74% of 854) showed no extracardiac pathologies. In the remaining 223 CMRI (26% of 854), a total of 286 extracardiac findings were detected. Among these findings, 49 were considered significant (group A) and 237 nonsignificant (group B). In group A, the most common findings were suspicious pulmonary nodules or masses. In group B, the most frequent findings were hepatic cysts or hemangiomas. Eight malignancies were observed with certainty at CMRI. Seven of them had been incidentally diagnosed on CMRI for the first time, and subsequently changed the patients' management.
CONCLUSION: Extracardiac findings in clinically indicated CMRI are common (about 26%). Radiologists and cardiologists should be aware of relevant extracardiac findings that might require additional diagnostics or treatment.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Keywords:  Cardiac MRI; cardiac diagnostic; cardiac imaging; extracardiac findings; heart disease; heart imaging

Mesh:

Substances:

Year:  2013        PMID: 23589475     DOI: 10.1002/jmri.24142

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  6 in total

1.  Incidental findings in cardiac magnetic resonance imaging: superiority of bSSFP over T1w-HASTE for extra-cardiac findings assessment.

Authors:  Jan M Sohns; Jan Menke; Alexander Schwarz; Leonard Bergau; Johannes T Kowallick; Andreas Schuster; Frank Konietschke; Marius Placzek; Desiree Weiberg; Stefan Nordlohne; Sebastian Schmuck; Sebastian Schulz; Thorsten Derlin; Wieland Staab
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-27       Impact factor: 2.357

2.  Extracardiac findings at cardiac MR imaging: a single-centre retrospective study over 14 years.

Authors:  Felix C Sokolowski; Philipp Karius; Alejandra Rodríguez; Alexander Lembcke; Moritz Wagner; Bernd Hamm; Marc Dewey
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

3.  Impact of extracardiac findings during cardiac MR on patient management and outcome.

Authors:  Vincent Dunet; Heloise Barras; Xavier Boulanger; Pierre Monney; Salah D Qanadli; Reto Meuli; Juerg Schwitter; Catherine Beigelman-Aubry
Journal:  Med Sci Monit       Date:  2015-05-06

Review 4.  Extra-cardiac findings in cardiovascular magnetic resonance: what the imaging cardiologist needs to know.

Authors:  Jonathan C L Rodrigues; Stephen M Lyen; William Loughborough; Antonio Matteo Amadu; Anna Baritussio; Amardeep Ghosh Dastidar; Nathan E Manghat; Chiara Bucciarelli-Ducci
Journal:  J Cardiovasc Magn Reson       Date:  2016-05-09       Impact factor: 5.364

5.  Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings.

Authors:  Elaine Rutherford; Jonathan R Weir-McCall; Rajan K Patel; J Graeme Houston; Giles Roditi; Allan D Struthers; Alan G Jardine; Patrick B Mark
Journal:  Eur Radiol       Date:  2016-04-07       Impact factor: 5.315

6.  Incidental Extracardiac Findings and Their Characterization on Cardiac MRI.

Authors:  Matteo Gravina; Luca Pio Stoppino; Grazia Casavecchia; Angelo Pio Moffa; Roberta Vinci; Natale Daniele Brunetti; Matteo Di Biase; Luca Macarini
Journal:  Biomed Res Int       Date:  2017-10-03       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.